Study Stopped
At the direction of our IRB, this project was incorporated into an existing study, LU#200038, NCT#02925156
Vitamin D Ancillary Study in 5 Populations of African Origin
VIDA
Determinants and Consequences of Low Vitamin D in Populations of African Descent
2 other identifiers
observational
N/A
5 countries
5
Brief Summary
The availability of data on plasma 25-Hydroxyvitamin D (25(OH)D) concentrations in the last two rounds of the National Health and Nutrition Examination Survey (NHANES) has generated a high level of interest in the consequences of 25(OH)D deficiency and in particular its potential impact on black Americans. Fundamental new questions about the biology of vitamin D have now come to the fore. Are low 25(OH)D-intact parathyroid hormone (iPTH) levels a physiologic "abnormality" in African Americans or does the 25(OH)D-iPTH system have sufficient plasticity to adapt to low sunlight exposure? Could the low 25(OH)D levels which result from the "gene- environment discordance" observed in dark skinned populations in the US be a risk factor for metabolic disorders? Ultimately, the public health community and regulatory bodies must offer recommendations for optimal levels and supplementation. The investigators propose to utilize cohorts from an ongoing NIH-funded study designed to identify determinants of weight change and cardiovascular disease risk in five Afro-origin populations \[Modeling the Epidemiologic Transition Study (METS)\] to examine these questions. The five METS countries include Ghana, Seychelles, South Africa, Jamaica and the US; the five populations differ greatly in terms of sun exposure and dietary intakes. In addition to the extensive energy expenditure, dietary intake and obesity-related metabolic markers being measured in METS, the investigators propose to assess plasma 25(OH)D, iPTH, serum and urinary calcium, plasma markers of bone resorption and formation, and quantitative ultrasound of the calcaneus. The associations of adiposity, weight change, cardiovascular disease (CVD) risk factors such as blood pressure and insulin, and bone strength with 25(OH)D and iPTH will be assessed. The proposed study will provide a comprehensive assessment of the distribution and determinants of 25(OH)D-iPTH and related physiologic measures across a wide range of latitude and lifestyles. These data should contribute substantially to the understanding of the "normal" range within which these hormones function and their significance in Afro- origin populations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2011
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 4, 2014
CompletedFirst Posted
Study publicly available on registry
April 11, 2014
CompletedAugust 30, 2017
August 1, 2017
Same day
April 4, 2014
August 28, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
25-Hydroxyvitamin D
Baseline
Parathyroid Hormone (iPTH)
Baseline
Blood Pressure
Baseline, 2.5 years
Body Composition
Body composition is estimated using bioelectrical impedance analysis (BIA) and race/sex specific equations. However, all participants will have body composition also measured using DXA (Dual energy x-ray absorptiometry).
Baseline, 2.5 years
Dietary Intake
Each participant will complete at least two 24-hour recalls using the multiple pass method during each examination, one at the initial clinic visit and the second when the activity monitor is collected.
Baseline, 2.5 years
Physical Activity
Accelerometer
Baseline, 2.5 years, 4 years
Bone Mineral Density
Dual energy x-ray absorptiometry (DXA) is a densitometry technique which provides a two-dimensional image of the bone being measured, to produce bone mineral density (BMD) values (mass of bone tissue per unit area).
2.5 years
Secondary Outcomes (3)
Serum Calcium
Baseline, 2.5 years
Serum Albumin
Baseline, 2.5 years
Urinary Calcium
Baseline, 2.5 years
Eligibility Criteria
A community-based probability sampling strategy is being used to recruit 500 adults, ages 25-44, from metropolitan Chicago, Spanish Town Jamaica, rural Ghana near Kumasi, Cape Town South Africa, and the Seychelles in the Indian Ocean
You may qualify if:
- Ages 25-44
You may not qualify if:
- Pregnant women will be excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Loyola Universitylead
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator
- Kwame Nkrumah University of Science and Technologycollaborator
- University of Cape Towncollaborator
- The University of The West Indiescollaborator
- University Institute of Social and Preventive Medicine, Switzerlandcollaborator
- University of Washingtoncollaborator
- Winthrop University Hospitalcollaborator
Study Sites (5)
Department of Public Health Sciences; Loyola University Chicago
Maywood, Illinois, 60153, United States
Kwame Nkrumah University of Science and Technology
Kumasi, Ghana
University of the West Indies
Kingston, Jamaica
University Institute of Social and Preventive Medicine
Victoria, Seychelles
University of Cape Town
Cape Town, South Africa
Related Publications (1)
Durazo-Arvizu RA, Camacho P, Bovet P, Forrester T, Lambert EV, Plange-Rhule J, Hoofnagle AN, Aloia J, Tayo B, Dugas LR, Cooper RS, Luke A. 25-Hydroxyvitamin D in African-origin populations at varying latitudes challenges the construct of a physiologic norm. Am J Clin Nutr. 2014 Sep;100(3):908-14. doi: 10.3945/ajcn.113.066605. Epub 2014 Jul 9.
PMID: 25008852DERIVED
Biospecimen
Blood Serum Urine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ramon A Durazo-Arvizu, PhD
Loyola University Chicago
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 4, 2014
First Posted
April 11, 2014
Study Start
September 1, 2011
Primary Completion
September 1, 2011
Study Completion
September 1, 2011
Last Updated
August 30, 2017
Record last verified: 2017-08